PMCPA Case
| Case number | AUTH/3647/5/22 |
| Company | Leo |
| Type | Voluntary admission |
| Issue | Uncertified promotional material on UK promotional website pages |
| Product | Kyntheum (brodalumab) |
| Material/channel | Promotional website (Dermaworld) – ‘At a glance’ and ‘Mode of action’ webpages |
| Key job codes/pages | At a glance tab: MAT-21384 May 2019; Mode of action tab: MAT-39266 Nov 2020 (global-approved uploaded to UK site) |
| Applicable Code | 2019 |
| Complaint received | 13 May 2022 |
| Case completed | 4 May 2023 |
| Panel findings | Breach Clauses 14.1 and 9.1; No breach Clause 2 |
| Appeal | No appeal |
| Sanctions | Undertaking received; additional sanctions not stated |
Download the full case report (PDF)
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
⭐ Business Intelligence Access
See the full compliance picture for every pharma company
291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.
One real case. One key lesson. Every week — free.